Endo Pharmaceuticals, Inc.
Recent News About Endo Pharmaceuticals, Inc.
-
Impax to pay $145M to settle Opana drug market manipulation claims from pharmacies, other direct purchasers
The lawsuit accused Impax Labs of agreeing with drugmaker Endo Pharmaceuticals to delay the entry of its Opana generic equivalent. The deal came quickly after a jury found in favor of Endo on the antitrust claims -
Class action suit says drug companies caused opioid crisis, heightened insurance costs
A Chicago class-action lawyer has filed a 97-page lawsuit in Chicago federal court against 13 drug companies and distributors, on behalf of a woman who alleges the companies promoted opioid use, knowing such painkillers were dangerously addictive, jacking up people's health insurance costs. -
Judge pauses Chicago opioid lawsuit; judges mull consolidating host of similar cases nationally
A federal judge has placed on hold the city of Chicago’s lawsuit accusing the makers of prescription painkillers like Oxycontin and Percocet – so-called “opioids” – of falsely marketing their drugs to doctors. defrauding City Hall and other employee health plan administrators, while giving time for a panel of federal judges to decide if the action should be consolidated with other similar lawsuits, brought by cities and others, now pending in other jurisdictions. -
Judge: Testosterone replacement drug bellwether OK to proceed vs Testim maker Auxilium
After two federal juries delivered $140 million verdicts against AbbVie, competing drugmaker Auxilium will be headed to trial over claims its testosterone replacement therapy drug Testim caused heart attacks in men who took the drug to treat “off-label” conditions, spurred by what plaintiffs alleged was misleading marketing from drugmakers. -
Drug makers' testosterone replacement drug injured Georgia resident, suit claims
A Georgia man is suing several drug makers, including GlaxoSmithKline and Auxilium, for alleged design defect, liability and negligence for injuries he suffered while taking testosterone drugs. -
Chicago given third try at pressing opioid deception fraud suit vs drugmakers
A Chicago federal judge is giving City Hall a third try to refine its opioid fraud lawsuit vs drugmakers. -
Some market manipulation claims vs Opana maker chopped under IL law, other states' laws
A Chicago federal judge has chopped a few counts from a huge putative class-action suit – based on laws of various states, including Illinois – accusing the maker of the prescription pain killer Opana of improperly keeping the price of its product high by paying off another pharmaceutical company to delay the release of a generic version of the drug. -
Judge says Walgreen, Rite Aid must show numbers to push allegations Opana drugmakers cheated them
A Chicago federal judge has kicked drug retailers Walgreen and Rite Aid from an antitrust lawsuit against the maker of prescription pain killer Opana, saying the retailers must provide hard dollar figures to back up their allegations that the drugmaker improperly paid off another pharmaceutical company to delay the release of the generic version of its pain killer, and keep the price of its name brand drug high. -
Judge tosses insurers' RICO class action vs testosterone drug makers, saying not specific enough
A federal judge has tossed, with leave to amend, the bulk of a federal racketeering and fraud class action brought by an Ohio-based health insurer against Abbvie and other makers of testosterone drugs, saying the insurer has not yet backed up with enough particularity its allegations the drugmakers invented the condition known as “low T,” and, through false marketing to doctors, patients and insurers alike, induced insurers and others to pay far more for the drugs to treat the condition.